Oak Grove Capital LLC Cuts Stake in Astera Labs, Inc. $ALAB

Oak Grove Capital LLC trimmed its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 6.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 81,200 shares of the company’s stock after selling 5,700 shares during the period. Astera Labs comprises 1.6% of Oak Grove Capital LLC’s holdings, making the stock its 15th biggest position. Oak Grove Capital LLC’s holdings in Astera Labs were worth $13,508,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Eurizon Capital SGR S.p.A. purchased a new stake in Astera Labs during the 4th quarter worth approximately $18,708,000. Nordea Investment Management AB purchased a new stake in shares of Astera Labs during the fourth quarter worth about $2,028,000. Geneva Partners LLC purchased a new stake in Astera Labs during the 3rd quarter worth approximately $1,876,000. Numerai GP LLC increased its position in shares of Astera Labs by 153.1% during the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares in the last quarter. Finally, Swedbank AB grew its holdings in shares of Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after buying an additional 33,940 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ALAB shares. Citigroup cut Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Susquehanna boosted their price target on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Morgan Stanley upped their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Evercore restated an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. Finally, Roth Mkm reaffirmed a “buy” rating and set a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $233.75.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. The trade was a 7.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161,256 shares of company stock valued at $459,844,296 in the last 90 days. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $417.07 on Friday. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $421.20. The company has a 50 day moving average price of $258.60 and a 200 day moving average price of $185.72. The stock has a market capitalization of $71.49 billion, a P/E ratio of 281.80, a PEG ratio of 4.96 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue was up 93.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.